ID   CH60_ECOLI              Reviewed;         548 AA.
AC   P0A6F5; P06139; Q2M6G1;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   28-JAN-2026, entry version 182.
DE   RecName: Full=Chaperonin GroEL {ECO:0000255|HAMAP-Rule:MF_00600, ECO:0000305};
DE            EC=5.6.1.7 {ECO:0000255|HAMAP-Rule:MF_00600, ECO:0000269|PubMed:9285585, ECO:0000269|PubMed:9285593};
DE   AltName: Full=60 kDa chaperonin {ECO:0000255|HAMAP-Rule:MF_00600};
DE   AltName: Full=Chaperonin-60 {ECO:0000255|HAMAP-Rule:MF_00600, ECO:0000303|PubMed:10532860};
DE            Short=Cpn60 {ECO:0000255|HAMAP-Rule:MF_00600, ECO:0000303|PubMed:10532860};
DE   AltName: Full=GroEL protein {ECO:0000305};
GN   Name=groEL {ECO:0000255|HAMAP-Rule:MF_00600,
GN   ECO:0000303|PubMed:7015340};
GN   Synonyms=groL {ECO:0000255|HAMAP-Rule:MF_00600}, mopA;
GN   OrderedLocusNames=b4143, JW4103;
OS   Escherichia coli (strain K12).
OC   Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria;
OC   Enterobacterales; Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RX   PubMed=2897629; DOI=10.1038/333330a0;
RA   Hemmingsen S.M., Woolford C., van der Vies S.M., Tilly K., Dennis D.T.,
RA   Georgopoulos C., Hendrix R.W., Ellis R.J.;
RT   "Homologous plant and bacterial proteins chaperone oligomeric protein
RT   assembly.";
RL   Nature 333:330-334(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=7610040; DOI=10.1093/nar/23.12.2105;
RA   Burland V.D., Plunkett G. III, Sofia H.J., Daniels D.L., Blattner F.R.;
RT   "Analysis of the Escherichia coli genome VI: DNA sequence of the region
RT   from 92.8 through 100 minutes.";
RL   Nucleic Acids Res. 23:2105-2119(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-86, AND FUNCTION.
RX   PubMed=2901493; DOI=10.1016/0022-2836(88)90141-6;
RA   Miki T., Orita T., Furuno M., Horiuchi T.;
RT   "Control of cell division by sex factor F in Escherichia coli. III.
RT   Participation of the groES (mopB) gene of the host bacteria.";
RL   J. Mol. Biol. 201:327-338(1988).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 298-495.
RX   PubMed=2578448; DOI=10.1128/jb.161.1.446-449.1985;
RA   Chanda P.K., Ono M., Kuwano M., Kung H.-F.;
RT   "Cloning, sequence analysis, and expression of alteration of the mRNA
RT   stability gene (ams+) of Escherichia coli.";
RL   J. Bacteriol. 161:446-449(1985).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-22.
RC   STRAIN=K12 / EMG2;
RX   PubMed=9298646; DOI=10.1002/elps.1150180807;
RA   Link A.J., Robison K., Church G.M.;
RT   "Comparing the predicted and observed properties of proteins encoded in the
RT   genome of Escherichia coli K-12.";
RL   Electrophoresis 18:1259-1313(1997).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-12.
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RA   Frutiger S., Hughes G.J., Pasquali C., Hochstrasser D.F.;
RL   Submitted (FEB-1996) to UniProtKB.
RN   [9]
RP   PROTEIN SEQUENCE OF 4-10.
RC   STRAIN=K12;
RX   PubMed=17895580; DOI=10.1266/ggs.82.291;
RA   Otsuka Y., Koga M., Iwamoto A., Yonesaki T.;
RT   "A role of RnlA in the RNase LS activity from Escherichia coli.";
RL   Genes Genet. Syst. 82:291-299(2007).
RN   [10]
RP   PROTEIN SEQUENCE OF 455-519.
RX   PubMed=7903255; DOI=10.1016/0014-5793(93)81600-5;
RA   Thomson G.J., Coggins J.R., Price N.C.;
RT   "The reaction of GroEL (cpn 60) with the ATP analogue 2',3' dialdehyde
RT   ATP.";
RL   FEBS Lett. 336:19-22(1993).
RN   [11]
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=379350; DOI=10.1016/0022-2836(79)90502-3;
RA   Hendrix R.W.;
RT   "Purification and properties of groE, a host protein involved in
RT   bacteriophage assembly.";
RL   J. Mol. Biol. 129:375-392(1979).
RN   [12]
RP   FUNCTION (MICROBIAL INFECTION), AND GENE NAME.
RX   PubMed=7015340; DOI=10.1073/pnas.78.3.1629;
RA   Tilly K., Murialdo H., Georgopoulos C.;
RT   "Identification of a second Escherichia coli groE gene whose product is
RT   necessary for bacteriophage morphogenesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 78:1629-1633(1981).
RN   [13]
RP   FUNCTION.
RX   PubMed=2573517; DOI=10.1002/j.1460-2075.1989.tb08517.x;
RA   Kusukawa N., Yura T., Ueguchi C., Akiyama Y., Ito K.;
RT   "Effects of mutations in heat-shock genes groES and groEL on protein export
RT   in Escherichia coli.";
RL   EMBO J. 8:3517-3521(1989).
RN   [14]
RP   FUNCTION, AND ACTIVITY REGULATION.
RX   PubMed=10532860; DOI=10.1038/342884a0;
RA   Goloubinoff P., Christeller J.T., Gatenby A.A., Lorimer G.H.;
RT   "Reconstitution of active dimeric ribulose bisphosphate carboxylase from an
RT   unfoleded state depends on two chaperonin proteins and Mg-ATP.";
RL   Nature 342:884-889(1989).
RN   [15]
RP   FUNCTION.
RX   PubMed=1676490; DOI=10.1038/352036a0;
RA   Martin J., Langer T., Boteva R., Schramel A., Horwich A.L., Hartl F.U.;
RT   "Chaperonin-mediated protein folding at the surface of groEL through a
RT   'molten globule'-like intermediate.";
RL   Nature 352:36-42(1991).
RN   [16]
RP   PHOSPHORYLATION.
RX   PubMed=1349729; DOI=10.1038/357167a0;
RA   Sherman M.Y., Goldberg A.L.;
RT   "Heat shock in Escherichia coli alters the protein-binding properties of
RT   the chaperonin groEL by inducing its phosphorylation.";
RL   Nature 357:167-169(1992).
RN   [17]
RP   SUBUNIT, AND INTERACTION WITH GROES.
RX   PubMed=1361169; DOI=10.1002/j.1460-2075.1992.tb05581.x;
RA   Langer T., Pfeifer G., Martin J., Baumeister W., Hartl F.U.;
RT   "Chaperonin-mediated protein folding: GroES binds to one end of the GroEL
RT   cylinder, which accommodates the protein substrate within its central
RT   cavity.";
RL   EMBO J. 11:4757-4765(1992).
RN   [18]
RP   FUNCTION, AND MUTAGENESIS OF GLU-461.
RX   PubMed=8104102; DOI=10.1016/0092-8674(93)90470-b;
RA   Horwich A.L., Low K.B., Fenton W.A., Hirshfield I.N., Furtak K.;
RT   "Folding in vivo of bacterial cytoplasmic proteins: role of GroEL.";
RL   Cell 74:909-917(1993).
RN   [19]
RP   FUNCTION.
RX   PubMed=7915201; DOI=10.1016/0092-8674(94)90533-9;
RA   Weissman J.S., Kashi Y., Fenton W.A., Horwich A.L.;
RT   "GroEL-mediated protein folding proceeds by multiple rounds of binding and
RT   release of nonnative forms.";
RL   Cell 78:693-702(1994).
RN   [20]
RP   MUTAGENESIS.
RX   PubMed=7935796; DOI=10.1038/371614a0;
RA   Fenton W.A., Kashi Y., Furtak K., Horwich A.L.;
RT   "Residues in chaperonin GroEL required for polypeptide binding and
RT   release.";
RL   Nature 371:614-619(1994).
RN   [21]
RP   FUNCTION.
RX   PubMed=7867798; DOI=10.1016/0014-5793(95)00041-7;
RA   Taguchi H., Yoshida M.;
RT   "Chaperonin releases the substrate protein in a form with tendency to
RT   aggregate and ability to rebind to chaperonin.";
RL   FEBS Lett. 359:195-198(1995).
RN   [22]
RP   SUBUNIT, AND INTERACTION WITH GROES.
RX   PubMed=8618836; DOI=10.1073/pnas.92.26.12021;
RA   Azem A., Diamant S., Kessel M., Weiss C., Goloubinoff P.;
RT   "The protein-folding activity of chaperonins correlates with the symmetric
RT   GroEL14(GroES7)2 heterooligomer.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:12021-12025(1995).
RN   [23]
RP   SUBUNIT, AND INTERACTION WITH GROES.
RX   PubMed=7638600; DOI=10.1126/science.7638600;
RA   Engel A., Hayer-Hartl M.K., Goldie K.N., Pfeifer G., Hegerl R., Mueller S.,
RA   da Silva A.C., Baumeister W., Hartl F.U.;
RT   "Functional significance of symmetrical versus asymmetrical GroEL-GroES
RT   chaperonin complexes.";
RL   Science 269:832-836(1995).
RN   [24]
RP   SUBUNIT, AND INTERACTION WITH GROES.
RX   PubMed=7638601; DOI=10.1126/science.7638601;
RA   Hayer-Hartl M.K., Martin J., Hartl F.U.;
RT   "Asymmetrical interaction of GroEL and GroES in the ATPase cycle of
RT   assisted protein folding.";
RL   Science 269:836-841(1995).
RN   [25]
RP   FUNCTION.
RX   PubMed=8861908; DOI=10.1016/s0092-8674(00)81342-2;
RA   Roseman A.M., Chen S., White H., Braig K., Saibil H.R.;
RT   "The chaperonin ATPase cycle: mechanism of allosteric switching and
RT   movements of substrate-binding domains in GroEL.";
RL   Cell 87:241-251(1996).
RN   [26]
RP   SUBUNIT, AND INTERACTION WITH GROES.
RX   PubMed=8663256; DOI=10.1074/jbc.271.27.16180;
RA   Toeroek Z., Vigh L., Goloubinoff P.;
RT   "Fluorescence detection of symmetric GroEL14(GroES7)2 heterooligomers
RT   involved in protein release during the chaperonin cycle.";
RL   J. Biol. Chem. 271:16180-16186(1996).
RN   [27]
RP   IDENTIFICATION BY 2D-GEL.
RX   PubMed=9298644; DOI=10.1002/elps.1150180805;
RA   VanBogelen R.A., Abshire K.Z., Moldover B., Olson E.R., Neidhardt F.C.;
RT   "Escherichia coli proteome analysis using the gene-protein database.";
RL   Electrophoresis 18:1243-1251(1997).
RN   [28]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, AND MUTAGENESIS OF
RP   ASP-398.
RX   PubMed=9285593; DOI=10.1038/42047;
RA   Rye H.S., Burston S.G., Fenton W.A., Beechem J.M., Xu Z., Sigler P.B.,
RA   Horwich A.L.;
RT   "Distinct actions of cis and trans ATP within the double ring of the
RT   chaperonin GroEL.";
RL   Nature 388:792-798(1997).
RN   [29]
RP   SUBUNIT, AND MUTAGENESIS OF ALA-2 AND GLU-76.
RX   PubMed=15327959; DOI=10.1016/j.jmb.2004.07.066;
RA   Qamra R., Srinivas V., Mande S.C.;
RT   "Mycobacterium tuberculosis GroEL homologues unusually exist as lower
RT   oligomers and retain the ability to suppress aggregation of substrate
RT   proteins.";
RL   J. Mol. Biol. 342:605-617(2004).
RN   [30]
RP   FUNCTION, AND DOMAIN.
RX   PubMed=16751100; DOI=10.1016/j.cell.2006.04.027;
RA   Tang Y.C., Chang H.C., Roeben A., Wischnewski D., Wischnewski N.,
RA   Kerner M.J., Hartl F.U., Hayer-Hartl M.;
RT   "Structural features of the GroEL-GroES nano-cage required for rapid
RT   folding of encapsulated protein.";
RL   Cell 125:903-914(2006).
RN   [31]
RP   FUNCTION.
RX   PubMed=16684774; DOI=10.1074/jbc.m601605200;
RA   Cliff M.J., Limpkin C., Cameron A., Burston S.G., Clarke A.R.;
RT   "Elucidation of steps in the capture of a protein substrate for efficient
RT   encapsulation by GroE.";
RL   J. Biol. Chem. 281:21266-21275(2006).
RN   [32]
RP   FUNCTION, AND DOMAIN.
RX   PubMed=18418386; DOI=10.1038/emboj.2008.77;
RA   Tang Y.C., Chang H.C., Chakraborty K., Hartl F.U., Hayer-Hartl M.;
RT   "Essential role of the chaperonin folding compartment in vivo.";
RL   EMBO J. 27:1458-1468(2008).
RN   [33]
RP   FUNCTION.
RX   PubMed=18987317; DOI=10.1073/pnas.0809794105;
RA   Apetri A.C., Horwich A.L.;
RT   "Chaperonin chamber accelerates protein folding through passive action of
RT   preventing aggregation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:17351-17355(2008).
RN   [34]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-117, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=K12 / JW1106, and K12 / MG1655 / ATCC 47076;
RX   PubMed=18723842; DOI=10.1074/mcp.m800187-mcp200;
RA   Zhang J., Sprung R., Pei J., Tan X., Kim S., Zhu H., Liu C.F.,
RA   Grishin N.V., Zhao Y.;
RT   "Lysine acetylation is a highly abundant and evolutionarily conserved
RT   modification in Escherichia coli.";
RL   Mol. Cell. Proteomics 8:215-225(2009).
RN   [35]
RP   FUNCTION.
RX   PubMed=19915138; DOI=10.1073/pnas.0911556106;
RA   Tyagi N.K., Fenton W.A., Horwich A.L.;
RT   "GroEL/GroES cycling: ATP binds to an open ring before substrate protein
RT   favoring protein binding and production of the native state.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:20264-20269(2009).
RN   [36]
RP   FUNCTION.
RX   PubMed=20603018; DOI=10.1016/j.cell.2010.05.027;
RA   Chakraborty K., Chatila M., Sinha J., Shi Q., Poschner B.C., Sikor M.,
RA   Jiang G., Lamb D.C., Hartl F.U., Hayer-Hartl M.;
RT   "Chaperonin-catalyzed rescue of kinetically trapped states in protein
RT   folding.";
RL   Cell 142:112-122(2010).
RN   [37]
RP   SUBCELLULAR LOCATION.
RX   PubMed=20094032; DOI=10.1038/emboj.2009.412;
RA   Winkler J., Seybert A., Konig L., Pruggnaller S., Haselmann U., Sourjik V.,
RA   Weiss M., Frangakis A.S., Mogk A., Bukau B.;
RT   "Quantitative and spatio-temporal features of protein aggregation in
RT   Escherichia coli and consequences on protein quality control and cellular
RT   ageing.";
RL   EMBO J. 29:910-923(2010).
RN   [38]
RP   SUCCINYLATION AT LYS-34; LYS-51; LYS-117; LYS-277; LYS-321 AND LYS-390.
RC   STRAIN=K12;
RX   PubMed=21151122; DOI=10.1038/nchembio.495;
RA   Zhang Z., Tan M., Xie Z., Dai L., Chen Y., Zhao Y.;
RT   "Identification of lysine succinylation as a new post-translational
RT   modification.";
RL   Nat. Chem. Biol. 7:58-63(2011).
RN   [39]
RP   FUNCTION.
RX   PubMed=22445172; DOI=10.1016/j.cell.2012.02.047;
RA   Clare D.K., Vasishtan D., Stagg S., Quispe J., Farr G.W., Topf M.,
RA   Horwich A.L., Saibil H.R.;
RT   "ATP-triggered conformational changes delineate substrate-binding and
RT   -folding mechanics of the GroEL chaperonin.";
RL   Cell 149:113-123(2012).
RN   [40]
RP   SUBCELLULAR LOCATION.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=22380631; DOI=10.1111/j.1365-2958.2012.08021.x;
RA   Li G., Young K.D.;
RT   "Isolation and identification of new inner membrane-associated proteins
RT   that localize to cell poles in Escherichia coli.";
RL   Mol. Microbiol. 84:276-295(2012).
RN   [41]
RP   FUNCTION.
RX   PubMed=24816391; DOI=10.1016/j.jmb.2014.04.018;
RA   Gupta A.J., Haldar S., Milicic G., Hartl F.U., Hayer-Hartl M.;
RT   "Active cage mechanism of chaperonin-assisted protein folding demonstrated
RT   at single-molecule level.";
RL   J. Mol. Biol. 426:2739-2754(2014).
RN   [42]
RP   SUBUNIT.
RX   PubMed=25912285; DOI=10.1016/j.jmb.2015.04.009;
RA   Haldar S., Gupta A.J., Yan X., Milicic G., Hartl F.U., Hayer-Hartl M.;
RT   "Chaperonin-assisted protein folding: relative population of asymmetric and
RT   symmetric GroEL:GroES complexes.";
RL   J. Mol. Biol. 427:2244-2255(2015).
RN   [43]
RP   ACTIVITY REGULATION, AND URIDYLYLATION.
RX   PubMed=32966796; DOI=10.1016/j.celrep.2020.108161;
RA   Yang Y., Yue Y., Song N., Li C., Yuan Z., Wang Y., Ma Y., Li H., Zhang F.,
RA   Wang W., Jia H., Li P., Li X., Wang Q., Ding Z., Dong H., Gu L., Li B.;
RT   "The YdiU Domain Modulates Bacterial Stress Signaling through Mn2+-
RT   Dependent UMPylation.";
RL   Cell Rep. 32:108161-108161(2020).
RN   [44]
RP   REVIEW.
RX   PubMed=19638247; DOI=10.1017/s0033583509004764;
RA   Horwich A.L., Fenton W.A.;
RT   "Chaperonin-mediated protein folding: using a central cavity to kinetically
RT   assist polypeptide chain folding.";
RL   Q. Rev. Biophys. 42:83-116(2009).
RN   [45]
RP   REVIEW.
RX   PubMed=26422689; DOI=10.1016/j.tibs.2015.07.009;
RA   Hayer-Hartl M., Bracher A., Hartl F.U.;
RT   "The GroEL-GroES chaperonin machine: a nano-cage for protein folding.";
RL   Trends Biochem. Sci. 41:62-76(2016).
RN   [46]
RP   REVIEW.
RX   PubMed=32446288; DOI=10.1002/1873-3468.13844;
RA   Balchin D., Hayer-Hartl M., Hartl F.U.;
RT   "Recent advances in understanding catalysis of protein folding by molecular
RT   chaperones.";
RL   FEBS Lett. 594:2770-2781(2020).
RN   [47] {ECO:0007744|PDB:1GRL}
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS), SUBUNIT, AND DOMAIN.
RX   PubMed=7935790; DOI=10.1038/371578a0;
RA   Braig K., Otwinowski Z., Hegde R.S., Boisvert D.C., Joachimiak A.,
RA   Horwich A.L., Sigler P.B.;
RT   "The crystal structure of the bacterial chaperonin GroEL at 2.8 A.";
RL   Nature 371:578-586(1994).
RN   [48] {ECO:0007744|PDB:1OEL}
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 2-548, AND SUBUNIT.
RX   PubMed=8846220; DOI=10.1038/nsb1295-1083;
RA   Braig K., Adams P.D., Bruenger A.T.;
RT   "Conformational variability in the refined structure of the chaperonin
RT   GroEL at 2.8-A resolution.";
RL   Nat. Struct. Biol. 2:1083-1094(1995).
RN   [49]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS).
RX   PubMed=8564544; DOI=10.1038/nsb0296-170;
RA   Boisvert D.C., Wang J., Otwinowski Z., Horwich A.L., Sigler P.B.;
RT   "The 2.4 A crystal structure of the bacterial chaperonin GroEL complexed
RT   with ATP gamma S.";
RL   Nat. Struct. Biol. 3:170-177(1996).
RN   [50] {ECO:0007744|PDB:1JON}
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 191-345.
RX   PubMed=8986757; DOI=10.1073/pnas.93.26.15024;
RA   Zahn R., Buckle A.M., Perrett S., Johnson C.M., Corrales F.J., Golbik R.,
RA   Fersht A.R.;
RT   "Chaperone activity and structure of monomeric polypeptide binding domains
RT   of GroEL.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:15024-15029(1996).
RN   [51] {ECO:0007744|PDB:1AON}
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 2-548 IN COMPLEX WITH GROES AND
RP   ADP, FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, AND DOMAIN.
RX   PubMed=9285585; DOI=10.1038/41944;
RA   Xu Z., Horwich A.L., Sigler P.B.;
RT   "The crystal structure of the asymmetric GroEL-GroES-(ADP)7 chaperonin
RT   complex.";
RL   Nature 388:741-750(1997).
RN   [52] {ECO:0007744|PDB:1DK7, ECO:0007744|PDB:1DKD}
RP   X-RAY CRYSTALLOGRAPHY (2.02 ANGSTROMS) OF 192-337.
RX   PubMed=10619429; DOI=10.1016/s0092-8674(00)81673-6;
RA   Chen L., Sigler P.B.;
RT   "The crystal structure of a GroEL/peptide complex: plasticity as a basis
RT   for substrate diversity.";
RL   Cell 99:757-768(1999).
RN   [53] {ECO:0007744|PDB:1PCQ, ECO:0007744|PDB:1PF9}
RP   X-RAY CRYSTALLOGRAPHY (2.81 ANGSTROMS) OF 2-525 IN COMPLEX WITH GROES AND
RP   ADP.
RX   PubMed=14517228; DOI=10.1093/emboj/cdg477;
RA   Chaudhry C., Farr G.W., Todd M.J., Rye H.S., Brunger A.T., Adams P.D.,
RA   Horwich A.L., Sigler P.B.;
RT   "Role of the gamma-phosphate of ATP in triggering protein folding by GroEL-
RT   GroES: function, structure and energetics.";
RL   EMBO J. 22:4877-4887(2003).
RN   [54] {ECO:0007744|PDB:1XCK}
RP   X-RAY CRYSTALLOGRAPHY (2.92 ANGSTROMS) OF 2-548, AND DOMAIN.
RX   PubMed=16288915; DOI=10.1016/j.jmb.2005.09.096;
RA   Bartolucci C., Lamba D., Grazulis S., Manakova E., Heumann H.;
RT   "Crystal structure of wild-type chaperonin GroEL.";
RL   J. Mol. Biol. 354:940-951(2005).
RN   [55] {ECO:0007744|PDB:2NWC}
RP   X-RAY CRYSTALLOGRAPHY (3.02 ANGSTROMS).
RX   PubMed=17554162; DOI=10.1107/s1744309107020295;
RA   Kiser P.D., Lodowski D.T., Palczewski K.;
RT   "Purification, crystallization and structure determination of native GroEL
RT   from Escherichia coli lacking bound potassium ions.";
RL   Acta Crystallogr. F 63:457-461(2007).
RN   [56] {ECO:0007744|PDB:3ZPZ, ECO:0007744|PDB:3ZQ0, ECO:0007744|PDB:3ZQ1}
RP   STRUCTURE BY ELECTRON MICROSCOPY (8.90 ANGSTROMS) OF 2-527 IN COMPLEX WITH
RP   GROES.
RX   PubMed=23746846; DOI=10.1016/j.cell.2013.04.052;
RA   Chen D.H., Madan D., Weaver J., Lin Z., Schroder G.F., Chiu W., Rye H.S.;
RT   "Visualizing GroEL/ES in the act of encapsulating a folding protein.";
RL   Cell 153:1354-1365(2013).
RN   [57] {ECO:0007744|PDB:3WVL}
RP   X-RAY CRYSTALLOGRAPHY (3.79 ANGSTROMS) IN COMPLEX WITH GROES AND ATP, AND
RP   SUBUNIT.
RX   PubMed=25174333; DOI=10.1016/j.jmb.2014.08.017;
RA   Koike-Takeshita A., Arakawa T., Taguchi H., Shimamura T.;
RT   "Crystal structure of a symmetric football-shaped GroEL:GroES2-ATP14
RT   complex determined at 3.8A reveals rearrangement between two GroEL rings.";
RL   J. Mol. Biol. 426:3634-3641(2014).
RN   [58] {ECO:0007744|PDB:5W0S}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS) OF 2-525.
RX   PubMed=28710336; DOI=10.1073/pnas.1704725114;
RA   Roh S.H., Hryc C.F., Jeong H.H., Fei X., Jakana J., Lorimer G.H., Chiu W.;
RT   "Subunit conformational variation within individual GroEL oligomers
RT   resolved by Cryo-EM.";
RL   Proc. Natl. Acad. Sci. U.S.A. 114:8259-8264(2017).
RN   [59] {ECO:0007744|PDB:5OPW, ECO:0007744|PDB:5OPX}
RP   X-RAY CRYSTALLOGRAPHY (3.19 ANGSTROMS) OF 2-548 IN COMPLEX WITH GROES,
RP   ACTIVITY REGULATION, AND MUTAGENESIS OF ALA-109.
RX   PubMed=29336887; DOI=10.1016/j.cell.2017.12.010;
RA   Yan X., Shi Q., Bracher A., Milicic G., Singh A.K., Hartl F.U.,
RA   Hayer-Hartl M.;
RT   "GroEL ring separation and exchange in the chaperonin reaction.";
RL   Cell 172:605-617.e11(2018).
CC   -!- FUNCTION: Together with its co-chaperonin GroES, plays an essential
CC       role in assisting protein folding (PubMed:10532860, PubMed:16751100,
CC       PubMed:1676490, PubMed:18418386, PubMed:18987317, PubMed:20603018,
CC       PubMed:24816391, PubMed:2573517, PubMed:2897629, PubMed:8104102,
CC       PubMed:9285593). The GroEL-GroES system forms a nano-cage that allows
CC       encapsulation of the non-native substrate proteins and provides a
CC       physical environment optimized to promote and accelerate protein
CC       folding, probably by preventing aggregation and by entropically
CC       destabilizing folding intermediates (PubMed:16751100, PubMed:18418386,
CC       PubMed:18987317, PubMed:20603018, PubMed:24816391). Rapid binding of
CC       ATP, followed by slower binding of the non-native substrate protein and
CC       GroES to the cis open ring of GroEL initiates productive folding of the
CC       non-native protein inside a highly stable GroEL-ATP-GroES complex
CC       (PubMed:19915138, PubMed:22445172, PubMed:9285585, PubMed:9285593).
CC       Binding of ATP and GroES induces conformational changes that result in
CC       the release of the substrate protein into a nano-cage compartment,
CC       within the GroEL central cavity, for folding in isolation
CC       (PubMed:16684774, PubMed:22445172, PubMed:8861908, PubMed:9285585). To
CC       discharge GroES and substrate protein, ATP hydrolysis in the cis ring
CC       is required to form a GroEL-ADP-GroES complex with decreased stability
CC       (PubMed:9285593). Finally, binding of ATP to the opposite trans ring of
CC       GroEL results in disassembly of the cis-ternary complex, which opens
CC       the cage and allows release of the folded protein (PubMed:9285585,
CC       PubMed:9285593). Proteins released in non-native form may be rapidly
CC       rebound by another GroEL complex until all of the initially bound
CC       polypeptide reaches native form (PubMed:7867798, PubMed:7915201). Can
CC       rescue kinetically trapped intermediates (PubMed:20603018). GroEL shows
CC       ATPase activity (PubMed:1676490, PubMed:379350, PubMed:9285593). ATP
CC       hydrolysis moves the reaction cycle forward but is not required for
CC       substrate folding (PubMed:9285593). {ECO:0000269|PubMed:10532860,
CC       ECO:0000269|PubMed:16684774, ECO:0000269|PubMed:16751100,
CC       ECO:0000269|PubMed:1676490, ECO:0000269|PubMed:18418386,
CC       ECO:0000269|PubMed:18987317, ECO:0000269|PubMed:19915138,
CC       ECO:0000269|PubMed:20603018, ECO:0000269|PubMed:22445172,
CC       ECO:0000269|PubMed:24816391, ECO:0000269|PubMed:2573517,
CC       ECO:0000269|PubMed:2897629, ECO:0000269|PubMed:379350,
CC       ECO:0000269|PubMed:7867798, ECO:0000269|PubMed:7915201,
CC       ECO:0000269|PubMed:8104102, ECO:0000269|PubMed:8861908,
CC       ECO:0000269|PubMed:9285585, ECO:0000269|PubMed:9285593}.
CC   -!- FUNCTION: Also plays a role in coupling between replication of the F
CC       plasmid and cell division of the cell. {ECO:0000269|PubMed:2901493}.
CC   -!- FUNCTION: (Microbial infection) Essential for the assembly of several
CC       bacteriophages. {ECO:0000269|PubMed:379350,
CC       ECO:0000269|PubMed:7015340}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + an unfolded polypeptide = ADP + phosphate + a
CC         folded polypeptide.; EC=5.6.1.7; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_00600, ECO:0000269|PubMed:9285585,
CC         ECO:0000269|PubMed:9285593};
CC   -!- ACTIVITY REGULATION: During the substrate-folding cycle, the two GroEL
CC       rings separate for effective substrate binding and chaperonin activity.
CC       Ring separation is triggered by ATP binding to the trans ring of the
CC       asymmetric GroEL:GroES complex and avoids formation of functionally
CC       impaired symmetric GroEL:GroES2 complexes (PubMed:29336887). Activity
CC       of the GroEL-GroES chaperonin complex requires Mg-ATP (PubMed:10532860,
CC       PubMed:9285593). UMPylation of the chaperone by SelO/YdiU negatively
CC       regulates its activity, and may facilitate survival under stress
CC       conditions (PubMed:32966796). {ECO:0000269|PubMed:10532860,
CC       ECO:0000269|PubMed:29336887, ECO:0000269|PubMed:32966796,
CC       ECO:0000269|PubMed:9285593}.
CC   -!- SUBUNIT: Forms a cylinder of 14 subunits composed of two heptameric
CC       rings stacked back-to-back (PubMed:1361169, PubMed:15327959,
CC       PubMed:7935790, PubMed:8846220, PubMed:9285585). Interacts with the co-
CC       chaperonin GroES (PubMed:1361169, PubMed:25174333, PubMed:7638600,
CC       PubMed:7638601, PubMed:8618836, PubMed:8663256, PubMed:9285585). Can
CC       form asymmetrical complexes, composed of one GroEL and one GroES, and
CC       symmetrical complexes, formed between one GroEL and two GroES oligomers
CC       (PubMed:1361169, PubMed:25174333, PubMed:7638600, PubMed:7638601,
CC       PubMed:8618836, PubMed:8663256). The asymmetrical complex is the
CC       functional unit (PubMed:25912285, PubMed:7638600, PubMed:7638601). It
CC       was suggested that the symmetric heterooligomer may represent a
CC       transient intermediate in the chaperonin protein folding cycle
CC       (PubMed:8618836, PubMed:8663256). Another study shows that the
CC       symmetric heterooligomers are substantially populated only in the
CC       presence of proteins that cannot be folded by the chaperonin
CC       (PubMed:25912285). {ECO:0000269|PubMed:1361169,
CC       ECO:0000269|PubMed:15327959, ECO:0000269|PubMed:25174333,
CC       ECO:0000269|PubMed:25912285, ECO:0000269|PubMed:7638600,
CC       ECO:0000269|PubMed:7638601, ECO:0000269|PubMed:7935790,
CC       ECO:0000269|PubMed:8618836, ECO:0000269|PubMed:8663256,
CC       ECO:0000269|PubMed:8846220, ECO:0000269|PubMed:9285585}.
CC   -!- INTERACTION:
CC       P0A6F5; P0AFG8: aceE; NbExp=3; IntAct=EBI-543750, EBI-542683;
CC       P0A6F5; P00887: aroH; NbExp=3; IntAct=EBI-543750, EBI-1125143;
CC       P0A6F5; P76213: cho; NbExp=3; IntAct=EBI-543750, EBI-545155;
CC       P0A6F5; P77279: fetA; NbExp=3; IntAct=EBI-543750, EBI-560090;
CC       P0A6F5; P19323: fhlA; NbExp=2; IntAct=EBI-543750, EBI-1113147;
CC       P0A6F5; P0A6F5: groEL; NbExp=11; IntAct=EBI-543750, EBI-543750;
CC       P0A6F5; P0A6F9: groES; NbExp=31; IntAct=EBI-543750, EBI-369169;
CC       P0A6F5; P09372: grpE; NbExp=3; IntAct=EBI-543750, EBI-547441;
CC       P0A6F5; P77329: hyfG; NbExp=4; IntAct=EBI-543750, EBI-548413;
CC       P0A6F5; P0AEX9: malE; NbExp=3; IntAct=EBI-543750, EBI-369910;
CC       P0A6F5; P0AEY3: mazG; NbExp=2; IntAct=EBI-543750, EBI-554166;
CC       P0A6F5; P0A817: metK; NbExp=2; IntAct=EBI-543750, EBI-546295;
CC       P0A6F5; P63386: mlaF; NbExp=4; IntAct=EBI-543750, EBI-561408;
CC       P0A6F5; P0A717: prs; NbExp=2; IntAct=EBI-543750, EBI-906827;
CC       P0A6F5; P0A7H0: recF; NbExp=4; IntAct=EBI-543750, EBI-556839;
CC       P0A6F5; P37745: rfbC; NbExp=3; IntAct=EBI-543750, EBI-557071;
CC       P0A6F5; P0AGB3: rpoH; NbExp=3; IntAct=EBI-543750, EBI-555342;
CC       P0A6F5; P45527: ubiU; NbExp=4; IntAct=EBI-543750, EBI-561157;
CC       P0A6F5; P0A9W0: ulaR; NbExp=4; IntAct=EBI-543750, EBI-560926;
CC       P0A6F5; P39177: uspG; NbExp=5; IntAct=EBI-543750, EBI-561722;
CC       P0A6F5; P37640: yhjB; NbExp=3; IntAct=EBI-543750, EBI-542016;
CC       P0A6F5; P76524: ypdF; NbExp=2; IntAct=EBI-543750, EBI-1128711;
CC       P0A6F5; P60010: ACT1; Xeno; NbExp=5; IntAct=EBI-543750, EBI-2169;
CC       P0A6F5; P13423: pagA; Xeno; NbExp=2; IntAct=EBI-543750, EBI-456868;
CC       P0A6F5; P00586: TST; Xeno; NbExp=2; IntAct=EBI-543750, EBI-7900146;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00600,
CC       ECO:0000269|PubMed:20094032, ECO:0000269|PubMed:22380631}.
CC       Note=Uniformly located in the cytoplasm (PubMed:20094032). Exclusively
CC       localized in foci, usually near 1 cell pole in mid-to-late exponential
CC       phase (PubMed:22380631); polar localization depends on the minCDE
CC       operon. Foci form near midcell (Probable).
CC       {ECO:0000269|PubMed:20094032, ECO:0000269|PubMed:22380631,
CC       ECO:0000305}.
CC   -!- DOMAIN: Each subunit is composed of an apical domain that binds non-
CC       folded proteins and GroES, an intermediate domain and an equatorial
CC       domain that binds ATP and is involved in inter-ring interactions
CC       (PubMed:16288915, PubMed:7935790). Forms a large central channel that
CC       appears to traverse the entire length of the cylinder with no
CC       obstruction (PubMed:7935790). The central channel of GroEL functions as
CC       two cavities, one in each ring, that are separated from each other by
CC       the crystallographically disordered 23-amino-acid C-terminal segments
CC       of the seven subunits (PubMed:9285585). The entry and exit of
CC       polypeptide seem to be restricted to the apical end of each ring
CC       (PubMed:9285585). {ECO:0000269|PubMed:16288915,
CC       ECO:0000269|PubMed:7935790, ECO:0000269|PubMed:9285585}.
CC   -!- DOMAIN: Modulating the volume of the GroEL central cavity affects
CC       folding speed in accordance with confinement theory. Small proteins
CC       fold more rapidly as the size of the cage is gradually reduced to a
CC       point where restriction in space slows folding dramatically. For larger
CC       proteins, either expanding or reducing cage volume decelerate folding
CC       (PubMed:16751100). A stepwise reduction in cage size results in a
CC       gradual loss of cell viability (PubMed:18418386).
CC       {ECO:0000269|PubMed:16751100, ECO:0000269|PubMed:18418386}.
CC   -!- PTM: Phosphorylated reversibly during heat shock.
CC       {ECO:0000269|PubMed:1349729}.
CC   -!- PTM: Can be UMPylated on a tyrosine residue by SelO/YdiU, probably
CC       under stress conditions. {ECO:0000269|PubMed:32966796}.
CC   -!- SIMILARITY: Belongs to the chaperonin (HSP60) family.
CC       {ECO:0000255|HAMAP-Rule:MF_00600}.
CC   -!- CAUTION: Was originally designated as the ams protein.
CC       {ECO:0000305|PubMed:2578448}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA23934.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X07850; CAA30698.1; -; Genomic_DNA.
DR   EMBL; U14003; AAA97042.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC77103.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE78145.1; -; Genomic_DNA.
DR   EMBL; X07899; CAA30739.1; -; Genomic_DNA.
DR   EMBL; M11294; AAA23934.1; ALT_FRAME; Genomic_DNA.
DR   PIR; S56371; BVECGL.
DR   RefSeq; NP_418567.1; NC_000913.3.
DR   RefSeq; WP_000729117.1; NZ_CP009789.1.
DR   PDB; 1AON; X-ray; 3.00 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 1DK7; X-ray; 2.02 A; A/B=191-336.
DR   PDB; 1DKD; X-ray; 2.10 A; A/B/C/D=191-336.
DR   PDB; 1FY9; X-ray; 2.20 A; A=191-376.
DR   PDB; 1FYA; X-ray; 2.20 A; A=191-376.
DR   PDB; 1GR5; EM; 7.90 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 1GRL; X-ray; 2.80 A; A/B/C/D/E/F/G=1-548.
DR   PDB; 1GRU; EM; 12.50 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 1JON; X-ray; 2.50 A; A=191-345.
DR   PDB; 1KID; X-ray; 1.70 A; A=188-376.
DR   PDB; 1KP8; X-ray; 2.00 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 1LA1; X-ray; 2.06 A; A=188-379.
DR   PDB; 1MNF; X-ray; 3.00 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 1OEL; X-ray; 2.80 A; A/B/C/D/E/F/G=2-548.
DR   PDB; 1PCQ; X-ray; 2.81 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-525.
DR   PDB; 1PF9; X-ray; 2.99 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-525.
DR   PDB; 1SS8; X-ray; 2.70 A; A/B/C/D/E/F/G=2-525.
DR   PDB; 1SVT; X-ray; 2.81 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-525.
DR   PDB; 1SX3; X-ray; 2.00 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-526.
DR   PDB; 1SX4; X-ray; 3.00 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-525.
DR   PDB; 1XCK; X-ray; 2.92 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 2C7C; EM; 7.70 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 2C7D; EM; 8.70 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 2C7E; EM; 9.70 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 2CGT; EM; 8.20 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 2EU1; X-ray; 3.29 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 2NWC; X-ray; 3.02 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 2YEY; X-ray; 3.30 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-525.
DR   PDB; 3C9V; EM; 4.70 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-527.
DR   PDB; 3CAU; EM; 4.20 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-527.
DR   PDB; 3VZ6; X-ray; 1.50 A; A=191-376.
DR   PDB; 3VZ7; X-ray; 1.80 A; A=191-376.
DR   PDB; 3VZ8; X-ray; 1.90 A; A/B/C=191-376.
DR   PDB; 3WVL; X-ray; 3.79 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 3ZPZ; EM; 8.90 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-527.
DR   PDB; 3ZQ0; EM; 9.20 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-525.
DR   PDB; 3ZQ1; EM; 15.90 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-527.
DR   PDB; 4AAQ; EM; 8.00 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 4AAR; EM; 8.00 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 4AAS; EM; 8.50 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 4AAU; EM; 8.50 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 4AB2; EM; 8.50 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 4AB3; EM; 8.50 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 4V43; X-ray; 3.52 A; 1/2/A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X/Y/Z=2-548.
DR   PDB; 4WGL; X-ray; 3.13 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 4WSC; X-ray; 3.04 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 5OPW; X-ray; 3.19 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 5OPX; X-ray; 3.64 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 5W0S; EM; 3.50 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-525.
DR   PDB; 7PBJ; EM; 3.40 A; Ad/Ae/Ak/Al/Ar/As/Ay/Az/Bf/Bg/Bm/Bn/Bt/Bu=2-525.
DR   PDB; 7PBX; EM; 3.43 A; Ac/Ad/Ai/Aj/Ao/Ap/Au/Av/Ba/Bb/Bg/Bh/Bm/Bn=2-525.
DR   PDB; 7VWX; EM; 7.60 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 7XOJ; EM; 2.80 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 7XOK; EM; 2.70 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 7XOL; EM; 3.26 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 7XOM; EM; 3.20 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 7XON; EM; 3.10 A; B=2-548.
DR   PDB; 7XOO; EM; 3.00 A; B=2-548.
DR   PDB; 7XOP; EM; 3.20 A; K=2-548.
DR   PDB; 7XOQ; EM; 3.30 A; K=2-548.
DR   PDB; 7XOR; EM; 3.30 A; K=2-548.
DR   PDB; 7XOS; EM; 3.20 A; K=2-548.
DR   PDB; 7YWY; EM; 3.40 A; G/H/I/J/K/L/S/T/U/V/W/X/Z/b=2-525.
DR   PDB; 8BA7; EM; 4.40 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 8BA8; EM; 3.40 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 8BA9; EM; 3.70 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-525.
DR   PDB; 8BAA; EM; 4.20 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 8BKZ; EM; 2.30 A; A/BA/C/E/G/I/K/M/O/Q/S/V/X/Z=1-548.
DR   PDB; 8BL2; EM; 2.30 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 8BL7; EM; 4.40 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 8BLC; EM; 2.70 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 8BLD; EM; 4.40 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 8BLE; EM; 4.00 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 8BLF; EM; 3.90 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 8BLY; EM; 3.20 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 8BM0; EM; 3.40 A; A/C/D/F/G/H/I/K/L/N/O/Q/R/T=1-548.
DR   PDB; 8BM1; EM; 2.70 A; A/C/D/F/G/H/I/K/L/N/O/Q/R/T=1-548.
DR   PDB; 8BMD; EM; 2.80 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 8BMO; EM; 3.40 A; A/B/C/E/F/H/I/J/L/M/O/P/R/S=1-548.
DR   PDB; 8BMT; EM; 2.50 A; A/BA/C/E/G/I/J/L/N/P/R/T/X/Z=1-548.
DR   PDB; 8P4M; EM; 2.50 A; A/B/C/D/E/F/G=1-548.
DR   PDB; 8P4N; EM; 2.90 A; A/B/C/D/E/F/G=2-548.
DR   PDB; 8P4O; EM; 3.04 A; A/B/C/D/E/F/G=2-548.
DR   PDB; 8QXS; EM; 3.12 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 8QXT; EM; 2.90 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 8QXU; EM; 12.00 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 8QXV; EM; 13.60 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=2-548.
DR   PDB; 8S32; EM; 2.45 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-548.
DR   PDB; 9C0B; EM; 3.26 A; H/I/J/K/L/M/N/O/P/Q/R/S/T/U=1-548.
DR   PDBsum; 1AON; -.
DR   PDBsum; 1DK7; -.
DR   PDBsum; 1DKD; -.
DR   PDBsum; 1FY9; -.
DR   PDBsum; 1FYA; -.
DR   PDBsum; 1GR5; -.
DR   PDBsum; 1GRL; -.
DR   PDBsum; 1GRU; -.
DR   PDBsum; 1JON; -.
DR   PDBsum; 1KID; -.
DR   PDBsum; 1KP8; -.
DR   PDBsum; 1LA1; -.
DR   PDBsum; 1MNF; -.
DR   PDBsum; 1OEL; -.
DR   PDBsum; 1PCQ; -.
DR   PDBsum; 1PF9; -.
DR   PDBsum; 1SS8; -.
DR   PDBsum; 1SVT; -.
DR   PDBsum; 1SX3; -.
DR   PDBsum; 1SX4; -.
DR   PDBsum; 1XCK; -.
DR   PDBsum; 2C7C; -.
DR   PDBsum; 2C7D; -.
DR   PDBsum; 2C7E; -.
DR   PDBsum; 2CGT; -.
DR   PDBsum; 2EU1; -.
DR   PDBsum; 2NWC; -.
DR   PDBsum; 2YEY; -.
DR   PDBsum; 3C9V; -.
DR   PDBsum; 3CAU; -.
DR   PDBsum; 3VZ6; -.
DR   PDBsum; 3VZ7; -.
DR   PDBsum; 3VZ8; -.
DR   PDBsum; 3WVL; -.
DR   PDBsum; 3ZPZ; -.
DR   PDBsum; 3ZQ0; -.
DR   PDBsum; 3ZQ1; -.
DR   PDBsum; 4AAQ; -.
DR   PDBsum; 4AAR; -.
DR   PDBsum; 4AAS; -.
DR   PDBsum; 4AAU; -.
DR   PDBsum; 4AB2; -.
DR   PDBsum; 4AB3; -.
DR   PDBsum; 4V43; -.
DR   PDBsum; 4WGL; -.
DR   PDBsum; 4WSC; -.
DR   PDBsum; 5OPW; -.
DR   PDBsum; 5OPX; -.
DR   PDBsum; 5W0S; -.
DR   PDBsum; 7PBJ; -.
DR   PDBsum; 7PBX; -.
DR   PDBsum; 7VWX; -.
DR   PDBsum; 7XOJ; -.
DR   PDBsum; 7XOK; -.
DR   PDBsum; 7XOL; -.
DR   PDBsum; 7XOM; -.
DR   PDBsum; 7XON; -.
DR   PDBsum; 7XOO; -.
DR   PDBsum; 7XOP; -.
DR   PDBsum; 7XOQ; -.
DR   PDBsum; 7XOR; -.
DR   PDBsum; 7XOS; -.
DR   PDBsum; 7YWY; -.
DR   PDBsum; 8BA7; -.
DR   PDBsum; 8BA8; -.
DR   PDBsum; 8BA9; -.
DR   PDBsum; 8BAA; -.
DR   PDBsum; 8BKZ; -.
DR   PDBsum; 8BL2; -.
DR   PDBsum; 8BL7; -.
DR   PDBsum; 8BLC; -.
DR   PDBsum; 8BLD; -.
DR   PDBsum; 8BLE; -.
DR   PDBsum; 8BLF; -.
DR   PDBsum; 8BLY; -.
DR   PDBsum; 8BM0; -.
DR   PDBsum; 8BM1; -.
DR   PDBsum; 8BMD; -.
DR   PDBsum; 8BMO; -.
DR   PDBsum; 8BMT; -.
DR   PDBsum; 8P4M; -.
DR   PDBsum; 8P4N; -.
DR   PDBsum; 8P4O; -.
DR   PDBsum; 8QXS; -.
DR   PDBsum; 8QXT; -.
DR   PDBsum; 8QXU; -.
DR   PDBsum; 8QXV; -.
DR   PDBsum; 8S32; -.
DR   PDBsum; 9C0B; -.
DR   AlphaFoldDB; P0A6F5; -.
DR   EMDB; EMD-1042; -.
DR   EMDB; EMD-1046; -.
DR   EMDB; EMD-1047; -.
DR   EMDB; EMD-1180; -.
DR   EMDB; EMD-1181; -.
DR   EMDB; EMD-1202; -.
DR   EMDB; EMD-13293; -.
DR   EMDB; EMD-13308; -.
DR   EMDB; EMD-13762; -.
DR   EMDB; EMD-15939; -.
DR   EMDB; EMD-15940; -.
DR   EMDB; EMD-15942; -.
DR   EMDB; EMD-15944; -.
DR   EMDB; EMD-16099; -.
DR   EMDB; EMD-16100; -.
DR   EMDB; EMD-16102; -.
DR   EMDB; EMD-16106; -.
DR   EMDB; EMD-16107; -.
DR   EMDB; EMD-16108; -.
DR   EMDB; EMD-16109; -.
DR   EMDB; EMD-16115; -.
DR   EMDB; EMD-16116; -.
DR   EMDB; EMD-16117; -.
DR   EMDB; EMD-16118; -.
DR   EMDB; EMD-16119; -.
DR   EMDB; EMD-16125; -.
DR   EMDB; EMD-17418; -.
DR   EMDB; EMD-17420; -.
DR   EMDB; EMD-17421; -.
DR   EMDB; EMD-17423; -.
DR   EMDB; EMD-17424; -.
DR   EMDB; EMD-17534; -.
DR   EMDB; EMD-17535; -.
DR   EMDB; EMD-17559; -.
DR   EMDB; EMD-17560; -.
DR   EMDB; EMD-17563; -.
DR   EMDB; EMD-17564; -.
DR   EMDB; EMD-17566; -.
DR   EMDB; EMD-17567; -.
DR   EMDB; EMD-17568; -.
DR   EMDB; EMD-17569; -.
DR   EMDB; EMD-17570; -.
DR   EMDB; EMD-17571; -.
DR   EMDB; EMD-17572; -.
DR   EMDB; EMD-17573; -.
DR   EMDB; EMD-18735; -.
DR   EMDB; EMD-18736; -.
DR   EMDB; EMD-18737; -.
DR   EMDB; EMD-18738; -.
DR   EMDB; EMD-19687; -.
DR   EMDB; EMD-2325; -.
DR   EMDB; EMD-2326; -.
DR   EMDB; EMD-2327; -.
DR   EMDB; EMD-31310; -.
DR   EMDB; EMD-31311; -.
DR   EMDB; EMD-32159; -.
DR   EMDB; EMD-32164; -.
DR   EMDB; EMD-33349; -.
DR   EMDB; EMD-33350; -.
DR   EMDB; EMD-33351; -.
DR   EMDB; EMD-33352; -.
DR   EMDB; EMD-33353; -.
DR   EMDB; EMD-33354; -.
DR   EMDB; EMD-33355; -.
DR   EMDB; EMD-33356; -.
DR   EMDB; EMD-33357; -.
DR   EMDB; EMD-33358; -.
DR   EMDB; EMD-3407; -.
DR   EMDB; EMD-3415; -.
DR   EMDB; EMD-5001; -.
DR   EMDB; EMD-5002; -.
DR   SMR; P0A6F5; -.
DR   BioGRID; 4263077; 1225.
DR   BioGRID; 852957; 8.
DR   ComplexPortal; CPX-2113; GroEL-GroES complex.
DR   DIP; DIP-339N; -.
DR   FunCoup; P0A6F5; 1645.
DR   IntAct; P0A6F5; 700.
DR   MINT; P0A6F5; -.
DR   STRING; 511145.b4143; -.
DR   ChEMBL; CHEMBL4296299; -.
DR   CarbonylDB; P0A6F5; -.
DR   iPTMnet; P0A6F5; -.
DR   MetOSite; P0A6F5; -.
DR   jPOST; P0A6F5; -.
DR   PaxDb; 511145-b4143; -.
DR   EnsemblBacteria; AAC77103; AAC77103; b4143.
DR   GeneID; 93777681; -.
DR   GeneID; 948665; -.
DR   KEGG; ecj:JW4103; -.
DR   KEGG; eco:b4143; -.
DR   KEGG; ecoc:C3026_22390; -.
DR   PATRIC; fig|1411691.4.peg.2557; -.
DR   EchoBASE; EB0594; -.
DR   eggNOG; COG0459; Bacteria.
DR   HOGENOM; CLU_016503_3_0_6; -.
DR   InParanoid; P0A6F5; -.
DR   OMA; TDTDKME; -.
DR   OrthoDB; 9766614at2; -.
DR   PhylomeDB; P0A6F5; -.
DR   BioCyc; EcoCyc:EG10599-MONOMER; -.
DR   BioCyc; MetaCyc:EG10599-MONOMER; -.
DR   BRENDA; 5.6.1.7; 2026.
DR   SABIO-RK; P0A6F5; -.
DR   EvolutionaryTrace; P0A6F5; -.
DR   PRO; PR:P0A6F5; -.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:1990220; C:GroEL-GroES complex; IDA:EcoCyc.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:EcoCyc.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IDA:EcoCyc.
DR   GO; GO:0140662; F:ATP-dependent protein folding chaperone; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IDA:EcoCyc.
DR   GO; GO:0016853; F:isomerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:EcoCyc.
DR   GO; GO:0051082; F:unfolded protein binding; IDA:EcoCyc.
DR   GO; GO:0006457; P:protein folding; IDA:ComplexPortal.
DR   GO; GO:0042026; P:protein refolding; IEA:UniProtKB-UniRule.
DR   GO; GO:0009408; P:response to heat; IEP:EcoliWiki.
DR   GO; GO:0009314; P:response to radiation; IMP:EcoCyc.
DR   GO; GO:0019068; P:virion assembly; IMP:EcoliWiki.
DR   CDD; cd03344; GroEL; 1.
DR   FunFam; 1.10.560.10:FF:000001; 60 kDa chaperonin; 1.
DR   FunFam; 3.50.7.10:FF:000001; 60 kDa chaperonin; 1.
DR   Gene3D; 3.50.7.10; GroEL; 1.
DR   Gene3D; 1.10.560.10; GroEL-like equatorial domain; 1.
DR   Gene3D; 3.30.260.10; TCP-1-like chaperonin intermediate domain; 1.
DR   HAMAP; MF_00600; CH60; 1.
DR   InterPro; IPR018370; Chaperonin_Cpn60_CS.
DR   InterPro; IPR001844; Cpn60/GroEL.
DR   InterPro; IPR002423; Cpn60/GroEL/TCP-1.
DR   InterPro; IPR027409; GroEL-like_apical_dom_sf.
DR   InterPro; IPR027413; GROEL-like_equatorial_sf.
DR   InterPro; IPR027410; TCP-1-like_intermed_sf.
DR   NCBIfam; TIGR02348; GroEL; 1.
DR   NCBIfam; NF000592; PRK00013.1; 1.
DR   NCBIfam; NF009487; PRK12849.1; 1.
DR   NCBIfam; NF009488; PRK12850.1; 1.
DR   NCBIfam; NF009489; PRK12851.1; 1.
DR   PANTHER; PTHR45633; 60 KDA HEAT SHOCK PROTEIN, MITOCHONDRIAL; 1.
DR   Pfam; PF00118; Cpn60_TCP1; 1.
DR   PRINTS; PR00298; CHAPERONIN60.
DR   SUPFAM; SSF52029; GroEL apical domain-like; 1.
DR   SUPFAM; SSF48592; GroEL equatorial domain-like; 1.
DR   SUPFAM; SSF54849; GroEL-intermediate domain like; 1.
DR   PROSITE; PS00296; CHAPERONINS_CPN60; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Chaperone; Cytoplasm;
KW   Direct protein sequencing; Isomerase; Nucleotide-binding;
KW   Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:9298646, ECO:0000269|Ref.8"
FT   CHAIN           2..548
FT                   /note="Chaperonin GroEL"
FT                   /id="PRO_0000063358"
FT   BINDING         30..33
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00600,
FT                   ECO:0000269|PubMed:25174333, ECO:0000305|PubMed:14517228,
FT                   ECO:0000305|PubMed:9285585, ECO:0007744|PDB:1AON,
FT                   ECO:0007744|PDB:1PCQ, ECO:0007744|PDB:1PF9,
FT                   ECO:0007744|PDB:3WVL"
FT   BINDING         51
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00600,
FT                   ECO:0000269|PubMed:25174333, ECO:0000305|PubMed:14517228,
FT                   ECO:0000305|PubMed:9285585, ECO:0007744|PDB:1AON,
FT                   ECO:0007744|PDB:1PF9, ECO:0007744|PDB:3WVL"
FT   BINDING         87..91
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00600,
FT                   ECO:0000269|PubMed:25174333, ECO:0000305|PubMed:14517228,
FT                   ECO:0000305|PubMed:9285585, ECO:0007744|PDB:1AON,
FT                   ECO:0007744|PDB:1PCQ, ECO:0007744|PDB:1PF9,
FT                   ECO:0007744|PDB:3WVL"
FT   BINDING         415
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00600,
FT                   ECO:0000269|PubMed:25174333, ECO:0000305|PubMed:14517228,
FT                   ECO:0000305|PubMed:9285585, ECO:0007744|PDB:1AON,
FT                   ECO:0007744|PDB:1PCQ, ECO:0007744|PDB:1PF9,
FT                   ECO:0007744|PDB:3WVL"
FT   BINDING         479..481
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00600,
FT                   ECO:0000269|PubMed:25174333, ECO:0000305|PubMed:14517228,
FT                   ECO:0000305|PubMed:9285585, ECO:0007744|PDB:1AON,
FT                   ECO:0007744|PDB:1PCQ, ECO:0007744|PDB:1PF9,
FT                   ECO:0007744|PDB:3WVL"
FT   BINDING         495
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00600,
FT                   ECO:0000269|PubMed:25174333, ECO:0000305|PubMed:14517228,
FT                   ECO:0000305|PubMed:9285585, ECO:0007744|PDB:1AON,
FT                   ECO:0007744|PDB:1PCQ, ECO:0007744|PDB:1PF9,
FT                   ECO:0007744|PDB:3WVL"
FT   MOD_RES         34
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000269|PubMed:21151122"
FT   MOD_RES         51
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000269|PubMed:21151122"
FT   MOD_RES         117
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:18723842"
FT   MOD_RES         117
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:21151122"
FT   MOD_RES         277
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000269|PubMed:21151122"
FT   MOD_RES         321
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000269|PubMed:21151122"
FT   MOD_RES         390
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000269|PubMed:21151122"
FT   MUTAGEN         2
FT                   /note="A->S: Complex stability is significantly decreased;
FT                   when associated with S-76, same residues as in
FT                   M.tuberculosis."
FT                   /evidence="ECO:0000269|PubMed:15327959"
FT   MUTAGEN         76
FT                   /note="E->S: Complex stability is significantly decreased;
FT                   when associated with S-2, same residues as in
FT                   M.tuberculosis."
FT                   /evidence="ECO:0000269|PubMed:15327959"
FT   MUTAGEN         109
FT                   /note="A->C: Forms inter-ring disulfide bonds. Prevents
FT                   ring separation and leads to the formation of high amounts
FT                   of symmetric GroEL:GroES2 complexes."
FT                   /evidence="ECO:0000269|PubMed:29336887"
FT   MUTAGEN         398
FT                   /note="D->A: Can bind ATP with normal affinity, but is
FT                   defective in ATPase activity. Binds non-native rhodanese,
FT                   but cannot release the protein."
FT                   /evidence="ECO:0000269|PubMed:9285593"
FT   MUTAGEN         461
FT                   /note="E->K: Temperature-sensitive lethal mutant. At
FT                   nonpermissive temperature, the rate of general translation
FT                   is reduced and a defined group of cytoplasmic proteins are
FT                   translated but fail to reach native form."
FT                   /evidence="ECO:0000269|PubMed:8104102"
FT   CONFLICT        83..86
FT                   /note="DAAG -> GALQ (in Ref. 5; CAA30739)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        262
FT                   /note="L -> A (in Ref. 1; CAA30698)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        267
FT                   /note="M -> I (in Ref. 1; CAA30698)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        343
FT                   /note="Q -> R (in Ref. 6; AAA23934)"
FT                   /evidence="ECO:0000305"
FT   STRAND          4..8
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   HELIX           9..28
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   STRAND          32..34
FT                   /evidence="ECO:0007829|PDB:7YWY"
FT   STRAND          37..40
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   STRAND          43..46
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   STRAND          48..50
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   HELIX           53..59
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   HELIX           65..85
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   HELIX           89..108
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   HELIX           113..134
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   HELIX           141..151
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   TURN            152..154
FT                   /evidence="ECO:0007829|PDB:1SS8"
FT   HELIX           156..169
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   STRAND          173..178
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   STRAND          181..184
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   STRAND          186..191
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   STRAND          193..196
FT                   /evidence="ECO:0007829|PDB:3VZ6"
FT   STRAND          199..201
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   HELIX           202..204
FT                   /evidence="ECO:0007829|PDB:3VZ6"
FT   TURN            208..211
FT                   /evidence="ECO:0007829|PDB:3VZ6"
FT   STRAND          212..217
FT                   /evidence="ECO:0007829|PDB:3VZ6"
FT   STRAND          219..227
FT                   /evidence="ECO:0007829|PDB:3VZ6"
FT   HELIX           230..233
FT                   /evidence="ECO:0007829|PDB:3VZ6"
FT   HELIX           234..243
FT                   /evidence="ECO:0007829|PDB:3VZ6"
FT   STRAND          247..254
FT                   /evidence="ECO:0007829|PDB:3VZ6"
FT   HELIX           256..267
FT                   /evidence="ECO:0007829|PDB:3VZ6"
FT   STRAND          269..271
FT                   /evidence="ECO:0007829|PDB:8BL2"
FT   STRAND          273..277
FT                   /evidence="ECO:0007829|PDB:3VZ6"
FT   STRAND          279..281
FT                   /evidence="ECO:0007829|PDB:3VZ6"
FT   HELIX           282..296
FT                   /evidence="ECO:0007829|PDB:3VZ6"
FT   STRAND          300..302
FT                   /evidence="ECO:0007829|PDB:1XCK"
FT   HELIX           303..305
FT                   /evidence="ECO:0007829|PDB:3VZ6"
FT   HELIX           309..311
FT                   /evidence="ECO:0007829|PDB:3VZ6"
FT   HELIX           314..316
FT                   /evidence="ECO:0007829|PDB:3VZ6"
FT   STRAND          317..325
FT                   /evidence="ECO:0007829|PDB:3VZ6"
FT   STRAND          330..335
FT                   /evidence="ECO:0007829|PDB:3VZ6"
FT   HELIX           339..355
FT                   /evidence="ECO:0007829|PDB:3VZ6"
FT   HELIX           359..375
FT                   /evidence="ECO:0007829|PDB:3VZ6"
FT   STRAND          376..380
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   HELIX           386..409
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   STRAND          411..413
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   TURN            414..416
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   HELIX           417..425
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   TURN            426..428
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   HELIX           434..446
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   HELIX           449..457
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   HELIX           462..471
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   STRAND          476..479
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   TURN            480..483
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   STRAND          484..487
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   TURN            488..492
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   STRAND          494..496
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   HELIX           497..515
FT                   /evidence="ECO:0007829|PDB:1KP8"
FT   STRAND          517..523
FT                   /evidence="ECO:0007829|PDB:1KP8"
SQ   SEQUENCE   548 AA;  57329 MW;  CD3A0FB505F74AD1 CRC64;
     MAAKDVKFGN DARVKMLRGV NVLADAVKVT LGPKGRNVVL DKSFGAPTIT KDGVSVAREI
     ELEDKFENMG AQMVKEVASK ANDAAGDGTT TATVLAQAII TEGLKAVAAG MNPMDLKRGI
     DKAVTAAVEE LKALSVPCSD SKAIAQVGTI SANSDETVGK LIAEAMDKVG KEGVITVEDG
     TGLQDELDVV EGMQFDRGYL SPYFINKPET GAVELESPFI LLADKKISNI REMLPVLEAV
     AKAGKPLLII AEDVEGEALA TLVVNTMRGI VKVAAVKAPG FGDRRKAMLQ DIATLTGGTV
     ISEEIGMELE KATLEDLGQA KRVVINKDTT TIIDGVGEEA AIQGRVAQIR QQIEEATSDY
     DREKLQERVA KLAGGVAVIK VGAATEVEMK EKKARVEDAL HATRAAVEEG VVAGGGVALI
     RVASKLADLR GQNEDQNVGI KVALRAMEAP LRQIVLNCGE EPSVVANTVK GGDGNYGYNA
     ATEEYGNMID MGILDPTKVT RSALQYAASV AGLMITTECM VTDLPKNDAA DLGAAGGMGG
     MGGMGGMM
//
